XML 14 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments
3 Months Ended
Mar. 31, 2012
Financial Instruments [Abstract]  
Financial Instruments

Note 2. Financial Instruments

The following table summarizes the fair value of our cash, cash equivalents and available-for-sale marketable securities held in our current investment portfolio:

 

                                 
    Amortized
Cost
    Gross
Unrealized
Gains
    Gross
Unrealized
(Losses)
    Fair Value  

March 31, 2012

                               

Cash

  $ 494,733     $ 0     $ 0     $ 494,733  

Cash equivalents

    8,960,020       0       0       8,960,020  

Marketable debt securities, current

    2,147,640       59       0       2,147,699  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total cash, cash equivalents, and marketable securities

  $ 11,602,393     $ 59       0     $ 11,602,452  
   

 

 

   

 

 

   

 

 

   

 

 

 

December 31, 2011

                               

Cash

  $ 291,093     $ 0     $ 0     $ 291,093  

Cash equivalents

    13,020,168       0       0       13,020,168  

Marketable debt securities, current

    3,283,209       0       (2,618     3,280,591  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total cash, cash equivalents, and marketable securities

  $ 16,594,470     $ 0     $ (2,618   $ 16,591,852  
   

 

 

   

 

 

   

 

 

   

 

 

 

 

Gross unrealized gains and losses on cash equivalents were not significant at March 31, 2012 and December 31, 2011. At March 31, 2012, our investment in money market accounts are composed primarily of U.S. Treasury debt securities, which are classified as cash equivalents in our Consolidated Balance Sheet due to their short maturities. Our investment in short-term marketable debt securities are composed primarily of commercial paper and corporate debt securities.